Emerg Infect Dis. 2022 Apr;28(4):717-724. doi: 10.3201/eid2804.211975.
To better guide the regional response to antimicrobial resistance (AMR), we report the burden of AMR over time in countries in the World Health Organization Eastern Mediterranean Region. To assess the capacities of national infection prevention and control and antimicrobial stewardship programs, we analyzed data on bloodstream infections reported to the Global Antimicrobial Resistance Surveillance System during 2017-2019, data from 7 countries on nationally representative surveys of antimicrobial prescriptions, and data from 2 regional surveys. The median proportion of bloodstream infections was highest for carbapenem-resistant Acinetobacter spp. (70.3%) and lowest for carbapenem-resistant Escherichia coli (4.6%). Results of the regional assessments indicate that few countries have capacities for infection prevention and control and antimicrobial stewardship programs to prevent emergence and spread of AMR. Overall, the magnitude of the problem and the limited capacity to respond emphasize the need for regional political leadership in addressing AMR.
为了更好地指导对抗微生物药物耐药性(AMR)的区域应对措施,我们报告了世界卫生组织东地中海区域各国 AMR 负担随时间变化的情况。为了评估国家感染预防和控制以及抗菌药物管理计划的能力,我们分析了 2017-2019 年向全球抗菌药物耐药性监测系统报告的血流感染数据、7 个国家关于全国代表性抗菌药物处方调查的数据以及 2 个区域调查的数据。血流感染中碳青霉烯类耐药不动杆菌属(70.3%)的比例最高,碳青霉烯类耐药大肠埃希菌(4.6%)的比例最低。区域评估的结果表明,很少有国家具备预防 AMR 的出现和传播的感染预防和控制以及抗菌药物管理计划的能力。总体而言,问题的严重程度和应对能力的有限性强调了需要在解决 AMR 方面采取区域政治领导。